The “modern clinician” is a practical and caring clinician who

realizes that therapeutic advancements in Parkinson’s disease

are occurring at an unprecedented pace. Much of today’s

treatment approach is based on clinical trial findings. Therefore,

it is important for clinicians to not only be updated with the

clinical trial results, but also to know the hypotheses behind

them, the strengths, weaknesses and other findings outside

the primary objectives of these clinical trials. This educational

program is unique because it intends to discuss the current

approaches to the treatment of Parkinson’s disease in the

context of the “lessons learned” in clinical trials to date. The

program also intends to provide a sneak peak of the future in

PD treatment based on planned and on-going clinical trials for

delaying disease progression and improving motor and nonmotor

symptoms of the disorder.

CoDirectors

Hubert Fernandez, MD

Co-Chair, PSG Executive Committee

Cleveland Clinic

Cleveland, Ohio

Michael Schwarzschild, MD, PhD

Chair, PSG Executive Committee

Harvard Medical School

Boston, Massachusetts

Local Organizing Committee

Eric Farbman, MD

Director of Movement Disorders Center

University of Nevada School of Medicine

Las Vegas, Nevada

Ryan Walsh MD, PhD

Director, Parkinson’s Disease and Movement

Disorders Program

Director, Huntington’s Disease Comprehensive Clinic

Cleveland Clinic Lou Ruvo Center for Brain Health

Las Vegas, Nevada

Faculty                                                  

Alberto Espay, MD

Associate Professor of Neurology

Clinical Research Director of the James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders

University of Cincinnati

Cincinnati, Ohio

Robert Hauser, MD, MBA

Former PSG Executive Committee Member

Professor of Neurology, Molecular Pharmacology and Physiology

Director, USF Byrd Parkinson’s Disease and Movement Disorders Center

University of South Florida

Tampa, Florida

Anthony Lang, OC, MD, FRCPC, FAAN, FCAHS, FRSC Former Chair, PSG Classic Motor Working Group

Movement Disorders Centre

Toronto Western Hospital

Toronto, Ontario, Canada

Peter LeWitt, MD, PhD

Chair, PSG Biomarkers Working Group

Professor of Neurology, Wayne State University School of Medicine

Director, Parkinson's Disease and Movement Disorders Program

Henry Ford West Bloomfield Hospital

Detroit, Michigan

Connie Marras, MD, PhD

Member, PSG Executive Committee

Former Chair, PSG Genetics and Environmental Risk Factors Working Group

Assistant Professor of Neurology

University of Toronto

Toronto, Ontario, Canada.

William Ondo, MD

Professor of Neurology

University of Texas Health Science Center at Houston

Houston Texas

Ronald Pfeiffer, MD

Professor and Vice Chair

Department of Neurology

University of Tennessee Health Science Center

Memphis, Tennessee

Stephen Reich, MD

Professor of Neurology

The Frederick Henry Prince Distinguished Professor in Neurology

Department of Neurology

University of Maryland School of Medicine

Baltimore, Maryland

Tanya Simuni, MD

Chair, PSG Classic Motor Working Group

Arthur C. Nielsen Professor of Neurology

Director, Parkinson's Disease and Movement Disorders Center

Northwestern University Feinberg School of Medicine

Chicago, Illinois

Michele Tagliati, MD, FAAN

Vice Chairman, Department of Neurology

Director of Movement Disorders

Cedars-Sinai Medical Center

Los Angeles, California

Caroline Tanner, MD, PhD, FAAN

Former Co-Chair, PSG Executive Committee

Director, Clinical Research

Parkinson’s Institute

Sunnyvale, California

Daniel Weintraub, MD

Member, PSG Executive Committee

Associate Professor of Psychiatry and Neurology

Perelman School of Medicine

University of Pennsylvania

Philadelphia, Pennsylvania

Learning Objective

After completing this activity, the participant will be able to do

the following:

• List the current and emerging treatment approaches for the

newly diagnosed Parkinson’s disease (PD) patient

• Describe the current and future treatment options for motor

complications in PD

• Recognize and treat the most common nonmotor problems

associated with PD

• Explain the role of deep brain stimulation (DBS) surgery and

other advanced therapies for PD

• Analyze the strengths and weaknesses of clinical trials

and their contribution to today’s evidence-based treatment

approach to PD

Fee includes: Syllabus, continental breakfasts, refreshment breaks, and Saturday lunch.

PSG Member

Investigator $100

Coordinator $50

PSG Member Non PSG Member

Physician $200

Resident/Fellow* $50

Non-Physician $100

*Letter from program director must be received in our office prior to the course to receive this fee.

All memberships will be verified before the meeting.

Exhibitor Package – Two Day Exhibit $2,500      

Includes: Two day exhibit Saturday & Sunday Feb. 8th & 9th, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)

Exhibitor Package – One Day Exhibit $2,000      

Includes: One day exhibit Saturday Feb. 8th only, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)

Exhibitor Package – One Day Exhibit $1,000      

Includes: One day exhibit Sunday Feb. 9th, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)